NCT05555667View on ClinicalTrials.gov

Long-term Sedation With Remimazolam Besylate in Critically Ill Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Light SedationMechanical Ventilation
Interventions
DRUG

Remimazolam besylate

Sedation drug

DRUG

Propofol

Propofol. Sedation drug

Trial Locations (1)

Unknown

RECRUITING

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER